"10.1371_journal.pgen.1003173","plos genetics","2013-03-27T00:00:00Z","Mia M Gaudet; Karoline B Kuchenbaecker; Joseph Vijai; Robert J Klein; Tomas Kirchhoff; Lesley McGuffog; Daniel Barrowdale; Alison M Dunning; Andrew Lee; Joe Dennis; Sue Healey; Ed Dicks; Penny Soucy; Olga M Sinilnikova; Vernon S Pankratz; Xianshu Wang; Ronald C Eldridge; Daniel C Tessier; Daniel Vincent; Francois Bacot; Frans B L Hogervorst; Susan Peock; Dominique Stoppa-Lyonnet; KConFab Investigators; Paolo Peterlongo; Rita K Schmutzler; Katherine L Nathanson; Marion Piedmonte; Christian F Singer; Mads Thomassen; Ontario Cancer Genetics Network; Thomas v O Hansen; Susan L Neuhausen; Ignacio Blanco; Mark H Greene; Judith Garber; Jeffrey N Weitzel; Irene L Andrulis; David E Goldgar; Emma D'Andrea; Trinidad Caldes; Heli Nevanlinna; Ana Osorio; Elizabeth J van Rensburg; Adalgeir Arason; Gad Rennert; Ans M W van den Ouweland; Annemarie H van der Hout; Carolien M Kets; Cora M Aalfs; Juul T Wijnen; Margreet G E M Ausems; HEBON; EMBRACE; Debra Frost; Steve Ellis; Elena Fineberg; Radka Platte; D Gareth Evans; Chris Jacobs; Julian Adlard; Marc Tischkowitz; Mary E Porteous; Francesca Damiola; GEMO Study Collaborators; Lisa Golmard; Laure Barjhoux; Michel Longy; Muriel Belotti; Sandra Fert Ferrer; Sylvie Mazoyer; Amanda B Spurdle; Siranoush Manoukian; Monica Barile; Maurizio Genuardi; Norbert Arnold; Alfons Meindl; Christian Sutter; Barbara Wappenschmidt; Susan M Domchek; Georg Pfeiler; Eitan Friedman; Uffe Birk Jensen; Mark Robson; Sohela Shah; Conxi Lazaro; Phuong L Mai; Javier Benitez; Melissa C Southey; Marjanka K Schmidt; Peter A Fasching; Julian Peto; Manjeet K Humphreys; Qin Wang; Kyriaki Michailidou; Elinor J Sawyer; Barbara Burwinkel; Pascal Guénel; Stig E Bojesen; Roger L Milne; Hermann Brenner; Magdalena Lochmann; The GENICA Network; Kristiina Aittomäki; Thilo Dörk; Sara Margolin; Arto Mannermaa; Diether Lambrechts; Jenny Chang-Claude; Paolo Radice; Graham G Giles; Christopher A Haiman; Robert Winqvist; Peter Devillee; Montserrat García-Closas; Nils Schoof; Maartje J Hooning; Angela Cox; Paul D P Pharoah; Anna Jakubowska; Nick Orr; Anna González-Neira; Guillermo Pita; M Rosario Alonso; Per Hall; Fergus J Couch; Jacques Simard; David Altshuler; Douglas F Easton; Georgia Chenevix-Trench; Antonis C Antoniou; Kenneth Offit","Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, United States of America; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Program in Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, New York, United States of America; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom; Genetics and Population Health Division, Queensland Institute of Medical Research, Brisbane, Australia; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Québec City, Québec, Canada; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon–Centre Léon Bérard, Lyon, France; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America; Centre dInnovation Génome Québec et Université McGill, Montreal, Québec, Canada; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands; Institut Curie, Department of Tumour Biology, Paris, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Kathleen Cuningham Consortium for Research into Familial Breast Cancer–Peter MacCallum Cancer Center, Melbourne, Australia; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy; University Hospital of Cologne, Cologne, Germany; Abramson Cancer Center, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America; Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America; Department of Obstetrics and Gyncology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America; Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL–Catalan Institute of Oncology, Barcelona, Spain; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States of America; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, Massachusetts, United States of America; Clinical Cancer Genetics (for the City of Hope Clinical Cancer Genetics Community Research Network), City of Hope, Duarte, California, United States of America; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America; Department of Surgery, Oncology, and Gastroenterology, University of Padua, Padua, Italy; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain; Department of Genetics, University of Pretoria, Pretoria, South Africa; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland; BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel; Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Genetics, University Medical Center, Groningen University, Groningen, The Netherlands; Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands; Department of Human Genetics and Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Clinical Genetics, Guys and St. Thomas NHS Foundation Trust, London, United Kingdom; Yorkshire Regional Genetics Service, Leeds, United Kingdom; Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom; South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom; National Cancer Genetics Network, UNICANCER Genetic Group, France; Cancer Genetics Unit, INSERM U916, Institut Bergonié, Université de Bordeaux, Bordeaux, France; Laboratoire de Génétique Chromosomique, Hôtel Dieu Centre Hospitalier, Chambéry, France; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy; Fiorgen Foundation for Pharmacogenomics and Unit of Medical Genetics, Department of Clinical Physiopathology, University of Florence, Florence, Italy; University Hospital of Schleswig-Holstein, University Kiel, Kiel, Germany; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University, Munich, Germany; University of Heidelberg, Heidelberg, Germany; Sheba Medical Center, Tel Aviv, Israel; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL–Catalan Institute of Oncology, Barcelona, Spain; Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany; Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America; London School of Hygiene and Tropical Medicine, London, United Kingdom; Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guys & St. Thomas NHS Foundation Trust in partnership with Kings College London, London, United Kingdom; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University of Paris-Sud, UMR-S 1018, Villejuif, France; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Bochum, Germany; Institute and Outpatient Clinic of Occupational Medicine, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany; Institute of Pathology, Medical Faculty of the University of Bonn, Bonn, Germany; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland; Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden; School of Medicine, Institute of Clinical Medicine, Pathology, and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; Vesalius Research Center, VIB, Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Belgium; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia; Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu, University of Oulu, Oulu University Hospital, Oulu, Finland; Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands; Division of Genetics and Epidemiology and Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, United Kingdom; Division of Breast Cancer Research, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom; Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Human Genotyping–CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain; Department of Molecular Biology and Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America; Departments of Genetics and Medicine, Harvard Medical School, Boston, Massachusetts, United States of America","Conceived and designed the experiments: P Hall, FJ Couch, J Simard, D Altshuler, DF Easton, G Chenevix-Trench, AC Antoniou, K Offit. Performed the experiments: MM Gaudet, KB Kuchenbaecker, J Vijai, RJ Klein, T Kirchhoff. Analyzed the data: MM Gaudet, KB Kuchenbaecker, J Vijai, RJ Klein, L McGuffog, D Barrowdale, AM Dunning, J Simard, D Altshuler, DF Easton, AC Antoniou, K Offit. Contributed reagents/materials/analysis tools: L McGuffog, D Barrowdale, AM Dunning, A Lee, J Dennis, S Healey, E Dicks, P Soucy, OM Sinilnikova, VS Pankratz, X Wang, RC Eldridge, DC Tessier, D Vincent, F Bacot, FBL Hogervorst, S Peock, D Stoppa-Lyonnet, P Peterlongo, RK Schmutzler, KL Nathanson, M Piedmonte, CF Singer, M Thomassen, TvO Hansen, SL Neuhausen, I Blanco, MH Greene, J Garber, JN Weitzel, IL Andrulis, DE Goldgar, E DAndrea, T Caldes, H Nevanlinna, A Osorio, EJ van Rensburg, A Arason, G Rennert, AMW van den Ouweland, AH van der Hout, CM Kets, CM Aalfs, JT Wijnen, MGEM Ausems, D Frost, S Ellis, E Fineberg, R Platte, DG Evans, C Jacobs, J Adlard, M Tischkowitz, ME Porteous, F Damiola, L Golmard, L Barjhoux, M Longy, M Belotti, SF Ferrer, S Mazoyer, AB Spurdle, S Manoukian, M Barile, M Genuardi, N Arnold, A Meindl, C Sutter, B Wappenschmidt, SM Domchek, G Pfeiler, E Friedman, UB Jensen, M Robson, S Shah, C Lazaro, PL Mai, J Benitez, MC Southey, MK Schmidt, PA Fasching, J Peto, MK Humphreys, Q Wang, K Michailidou, EJ Sawyer, B Burwinkel, P Guénel, SE Bojesen, RL Milne, H Brenner, M Lochmann, K Aittomäki, T Dörk, S Margolin, A Mannermaa, D Lambrechts, J Chang-Claude, P Radice, GG Giles, CA Haiman, R Winqvist, P Devillee, M García-Closas, N Schoof, MJ Hooning, A Cox, PDP Pharoah, A Jakubowska, N Orr, A González-Neira, G Pita, MR Alonso, P Hall, FJ Couch, DF Easton, G Chenevix-Trench, AC Antoniou, K Offit. Wrote the paper: MM Gaudet, KB Kuchenbaecker, J Vijai, RJ Klein, AC Antoniou, K Offit.","The authors have declared that no competing interests exist.","2013","03","Mia M Gaudet","MMG",132,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
